IndiaOne Finance - Company Dashboard

Governance Classic Home

Kopran LtdPharmaceuticalsINE082A01010Consolidated₹277.60+9.01 (+3.35%)Jun-26

Valuation

Market Cap₹1.34K Cr

TTM PE53.69x

Forward PE28.80x

PEG-19.04

Book Value₹109.82

P/B2.53x

TTM EPS₹5.17

Fwd EPS₹9.64

TTM Revenue₹700.20 Cr

TTM PAT₹24.99 Cr

TTM EBITDA₹61.23 Cr

TTM EBIT₹42.24 Cr

Last Qtr PAT₹6.70 Cr

Last Qtr EBITDA₹15.79 Cr

Last Qtr EBIT₹10.02 Cr

Profitability

ROE4.71%

ROCE8.22%

TTM NPM3.57%

TTM EBITDA %8.74%

Curr OPM4.29%

Last OPM8.06%

Curr NPM—

Last NPM—

Curr EPS₹1.39

Last EPS₹3.91

Balance sheet

Equity₹48.29 Cr

Reserve₹481.99 Cr

Total Debt₹152.69 Cr

D/E0.29x

Interest %48.96%

Curr Interest₹3.28 Cr

Price / range

Close₹277.60

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+3.35%

1W+18.00%

1M+37.76%

3M+50.23%

6M+135.45%

1Y+60.00%

2Y-17.78%

3Y+18.13%

5Y+31.16%

Diwali+83.23%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	62.76+22.3%	118.04	93.88	42.39	51.33	305.65
Other Income	2.91	1	0.32	0.32	1.80	2
Total Income	65.67+23.6%	119.04	94.20	42.71	53.13	307.65
Interest	1.24	1.17	1.16	0.83	1.04	4.20
Expenditure	-56.89-17.3%	-93.97	-78.62	-47.58	-48.52	-267.25
PBDT	0	0	0	0	0	0
EBITDA	8.46+66.9%	26.58	17.68	-3.20	5.07	47.58
Depreciation	-1.35	-1.34	-1.26	-1.16	-1.22	-4.98
EBIT	7.11+84.7%	25.24	16.42	-4.36	3.85	42.60
PBT	8.78+90.5%	25.07	15.58	-4.87	4.61	40.39
Tax	-2.06	-6.33	-3.45	0.88	-1.09	-9.99
Equity	48.29	48.29	0	0	48.29	48.29
OPM	13.37	21.06	16.60	-11.49	8.68	13.13
Net Profit	6.72+90.9%	18.74	12.13	-3.99	3.52	30.40
NPM	10.23	15.74	12.92	-9.42	6.63	9.88
EPS	1.39+90.4%	3.88	2.51	-0.83	0.73	6.30

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	305.65+12.8%	271.01-19.7%	337.46+23.6%	273.10+33.5%	204.52-8.2%	222.83
Other Income	2	5.90	16.71	16.09	8.03	10.41
Total Income	307.65+11.1%	276.91-21.8%	354.17+22.5%	289.18+36.1%	212.55-8.9%	233.25
Expenditure	-267.25-10.8%	-241.12+22.1%	-309.65-22.7%	-252.27-28.5%	-196.38+2.1%	-200.54
Interest	-4.20	-3.77	-4.50	-2.67	-2.95	-3.81
PBDT	0	0	0	0	0	0
EBITDA	47.58+23.1%	38.66+4.7%	36.93+32.3%	27.91+81.1%	15.41-49.0%	30.20
Depreciation	-4.98	-5	-4.62	-4.41	-4.32	-4.10
EBIT	42.60+26.6%	33.66+4.2%	32.31+37.5%	23.50+111.9%	11.09-57.5%	26.10
PBT	40.39+12.9%	35.79-19.6%	44.52+20.6%	36.92+128.5%	16.16-50.6%	32.71
Tax	-9.99	-8.94	-9.88	-5.66	-4.42	-9.23
Equity	48.29	48.29	0	0	0	0
OPM (%)	13.13	12.93	13.00	13.00	8.00	14.00
Net Profit	30.40+13.2%	26.86-22.5%	34.64+10.8%	31.25+166.2%	11.74-50.0%	23.47
NPM (%)	9.88	9.70	10.00	11.00	6.00	10.00
EPS (Rs)	6.30+13.1%	5.57-22.4%	7.18+10.8%	6.48+144.5%	2.65-51.2%	5.43
CEPS	6.30	5.57	7.17	6.48	2.65	5.43

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	153.99+13.9%	234.02	194.28	117.91	135.22	681.42
Other Income	2.05	0.09	0.07	0.03	2.56	0.35
Total Income	156.05+13.3%	234.11	194.35	117.94	137.77	681.77
Interest	3.28	3.17	2.67	2.09	2.54	10.47
Expenditure	-147.25-15.1%	-208.76	-183.60	-129.56	-127.88	-647.41
PBDT	0	0	0	0	0	0
EBITDA	15.79+11.7%	32.95	17.77	-5.28	14.14	61.95
Depreciation	-5.77	-4.52	-4.42	-4.28	-4.26	-17.47
EBIT	10.02+1.4%	28.43	13.35	-9.56	9.88	44.48
PBT	8.80-11.0%	25.35	10.75	0	9.89	34.36
Tax	-2.10	-6.48	-1.41	1.70	-2.44	-8.63
Equity	48.29	48.29	0	0	48.29	48.29
OPM	5.64	10.83	5.53	0.00	7.18	5.04
Net Profit	6.70-10.1%	18.87	9.34	-9.92	7.45	25.73
NPM	4.29	8.06	4.81	-8.41	5.41	3.77
EPS	1.39-9.7%	3.91	1.93	-2.06	1.54	5.33

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	681.42+8.2%	629.60+2.4%	614.59+11.5%	550.99+15.4%	477.52-2.9%	491.81
Other Income	0.35	3.98	14.61	3.07	10.61	17.99
Total Income	681.77+7.6%	633.59+0.7%	629.20+13.6%	554.05+13.5%	488.13-4.3%	509.80
Expenditure	-647.41-11.3%	-581.64-3.6%	-561.66-8.4%	-517.99-27.5%	-406.35+4.7%	-426.46
Interest	-10.47	-9.34	-8.59	-6.08	-5.12	-6.24
PBDT	0	0	0	0	0	0
EBITDA	61.95-15.0%	72.89-2.0%	74.41+43.7%	51.79-40.7%	87.39+6.9%	81.78
Depreciation	-17.47	-15.59	-12.89	-12.71	-11.10	-10.19
EBIT	44.48-22.4%	57.30-6.9%	61.52+57.4%	39.08-48.8%	76.29+6.6%	71.59
PBT	34.36-33.9%	51.95-23.1%	67.55+87.3%	36.07-55.9%	81.78-1.9%	83.34
Tax	-8.63	-13.40	-16.59	-8.83	-20.75	-21.73
Equity	48.29	48.21	0	0	0	0
OPM (%)	5.04	8.20	10.74	6.51	16.75	16.35
Net Profit	25.73-33.3%	38.55-24.4%	50.96+87.1%	27.23-55.4%	61.03-0.9%	61.61
NPM (%)	3.77	6.08	8.10	4.92	12.50	12.08
EPS (Rs)	5.33-33.3%	7.99-24.4%	10.57+87.1%	5.65-59.0%	13.77-3.3%	14.24
CEPS	5.33	7.99	10.55	5.65	13.77	14.24

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	3	11 Aug 2026
2025	Final Dividend	3	04 Sep 2025
2024	Final Dividend	3	02 Sep 2024
2023	Final Dividend	3	07 Sep 2023
2022	Final Dividend	3	04 Aug 2022
2021	Final Dividend	1.5	05 Aug 2021
2021	Interim Dividend	1.5	05 Nov 2020

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split